Doctor of Philosophy, The Ohio State University, 2019, Biomedical Engineering
Currently, most assays for cancer chemotherapeutic screening and development utilize two dimensional (2D) culturing systems. These 2D systems lack aspects of the in vivo microenvironment creating a poor in vitro representation that significantly affects cellular responses. To recapitulate the in vivo cellular microenvironment more closely, three dimensional (3D) cell culture systems have been developed and utilized. However, 3D cell culture systems are more complex, making analysis of cellular responses more difficult. Therefore, most high throughput (HT) 3D assays have been limited to measurements of cell viability. Yet other cellular functions play critical role in diseases and are promising pharmacological targets. There is a need for a HT 3D culturing system that enables the measurement of cellular functions, other than viability, for drug testing applications. To address this need, we developed, characterized, validated and demonstrated the utility of a HT 3D culturing system to measure matrix metalloproteinase (MMP) and metabolic activity, simultaneously. MMPs are critical regulators of tissue homeostasis and are upregulated in many diseases, such as arthritis and cancer. The developed assay produced edge effect, drift, Z'-factor, %CV, inter-plate, and inter-day fold shifts of the signals that were within the acceptable range for HT applications, designating it suitable for screening applications. Human MMP-1, -2 and -9 resulted in a significant increase in signal intensity. Encapsulation of several cell types, utilizing two different MMP-degradable peptides, produced robust signals above background noise and within the linear range of the assay. Finally, the utility of the system to measure cellular MMP activity in response to chemotherapeutics was demonstrated. Fibrosarcoma cell line (HT1080) was treated with several drugs, known to alter MMP activity, over a range of concentrations. Interestingly, sorafenib (SOR), a small molecule multi-kinase inhibitor uti (open full item for complete abstract)
Committee: Jennifer Leight Ph.D. (Advisor); Jessica Winter Ph.D. (Committee Member); Keith Gooch Ph.D. (Committee Member)
Subjects: Biomedical Engineering